Yazar "Göksugur, Nadir" seçeneğine göre listele
Listeleniyor 1 - 5 / 5
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Medical image Tularaemic cervical lymphadenopathy(2007) Karabay, Oğuz; Yılmaz, Fahrettin; Gürcan, Şaban; Göksugur, Nadir[No abstract available]Öğe Medical image. Extensive oral ulcerations.(2006) Göksugur, Nadir; Yılmaz, Fahrettin[No abstract available]Öğe Melkersson Rosenthal syndrome associated with ipsilateral facial, hand, and foot swelling(2008) Aliaǧaoǧlu, Cihangir; Yıldırım, Ümran; Albayrak, Hülya; Göksugur, Nadir; Memişoǧulları, Ramazan; Kavak, AyşeMelkersson-Rosenthal syndrome is a complex neuromucocutaneous disorder. A 60-year-old woman presented with granulomatous cheilitis of the lower lip, unilateral facial paralysis, and ipsilateral facial and acral swelling. The result of histopathological evaluation in extremities and inferior lip was compatible with Melkersson-Rosenthal syndrome. © 2008 Dermatology Online Journal.Öğe Primer cutaneous actinomycosis in diabetic patients(2011) Alia?ao?lu, Cihangir; Yildirim, Ümran; Albayrak, Hüya; Göksugur, Nadir; Özçelik, DeryaActinomycosis is a chronic suppurative granulomatous infection caused by gram positive bacterium. Enfection especially affects the head, neck, thorax and abdomen. Primary cutaneous involvement is uncommon and has an association with trauma and local ischemia. We present one such case of primary cutaneous actinomycosis on the elbow of a 68 year old man with diabetes and external trauma. This patient was admitted to our clinic with a 10-12cm size blue-purple plaque. Skin biopsy revealed the characteristic 'sulphur granules' of actinomycosis in the deep dermis After the diagnosis, initially he was treated with penisilin and cotrimaxazol with a little effect. Treatment was continued with amoksisilin and cotrimaxazol and he respond to this medical treatment partially. After this medical therapy skin graft operation was performed. Lesions relapsed six months later. Medical therapy was repeated and still continues.Öğe Serum visfatin, adiponectin, and tumor necrosis factor alpha (TNF-alpha) levels in patients with psoriasis and their correlation with disease severity(Croation Dermatovenerological Soc, 2016) Şereflican, Betül; Göksugur, Nadir; Buğdaycı, Güler; Polat, Mualla; Parlak, Ali HaydarPsoriasis is a chronic, autoimmune, and inflammatory disease of unknown etiology, characterized by T lymphocyte mediated keratinocyte proliferation. In recent years the relationship between psoriasis and adipose tissue cytokines has been reported. Psoriasis as a triggering factor for the immune and metabolic disorders can be associated with diabetes mellitus, abnormal lipid metabolism, and metabolic syndrome. In this study we assessed the adipose tissue cytokines visfatin, adiponectin, and tumor necrosis factor-alpha (TNF-alpha) levels in psoriasis patients and evaluated the relationship between disease severity and cytokines. The study included 42 patients with psoriasis and 42 healthy individuals. Visfatin, adiponectin, and TNF-alpha levels were measured in both the psoriasis and the control group. The disease severity index was assessed in psoriatic patients by means of PASI. The relationship between visfatin, adiponectin, TNF-alpha, PASI score, and obesity was evaluated. When serum TNF-alpha, adiponectin, and visfatin levels of the patient group were compared with those of the control group, the TNF-alpha levels were statistically higher (p = 0.00) and the adiponectin levels were statistically lower (p = 0.024). The visfatin levels were higher in the psoriatic patients compared to the control group, but this difference was not statistically significant (p = 0.73). The relationship between PASI-TNF-alpha and between PASI-adiponectin was statistically significant (p = 0.009 and p = 0.004). A positive correlation was observed between body mass index (BMI) and visfatin (p = 0.031). These results indicate that TNF-alpha and adiponectin play a part in psoriasis etiopathogenesis and can be used as parameters to evaluate the severity of the disease. However, the role of visfatin in psoriasis pathogenesis is unclear. Further clinical studies are needed to clarify the effect of visfatin in psoriatic patients.